Journal article Open Access

The Past, Present, and Future of Breast Cancer Models for Nanomedicine Development

Boix-Montesinos, Paz; Soriano-Teruel, Paula M; Armiñán, Ana; Orzáez, Mar; Vicent, María J


JSON Export

{
  "files": [
    {
      "links": {
        "self": "https://zenodo.org/api/files/65925d61-7099-4bfb-95bb-6cac6933a218/Breast%20Cancer%20Review%20Proof.pdf"
      }, 
      "checksum": "md5:9628f588b87e17f14ce36fc31c51d2a1", 
      "bucket": "65925d61-7099-4bfb-95bb-6cac6933a218", 
      "key": "Breast Cancer Review Proof.pdf", 
      "type": "pdf", 
      "size": 2353425
    }
  ], 
  "owners": [
    31980
  ], 
  "doi": "10.1016/j.addr.2021.03.018", 
  "stats": {
    "version_unique_downloads": 11.0, 
    "unique_views": 9.0, 
    "views": 9.0, 
    "version_views": 9.0, 
    "unique_downloads": 11.0, 
    "version_unique_views": 9.0, 
    "volume": 25887675.0, 
    "version_downloads": 11.0, 
    "downloads": 11.0, 
    "version_volume": 25887675.0
  }, 
  "links": {
    "doi": "https://doi.org/10.1016/j.addr.2021.03.018", 
    "latest_html": "https://zenodo.org/record/4663679", 
    "bucket": "https://zenodo.org/api/files/65925d61-7099-4bfb-95bb-6cac6933a218", 
    "badge": "https://zenodo.org/badge/doi/10.1016/j.addr.2021.03.018.svg", 
    "html": "https://zenodo.org/record/4663679", 
    "latest": "https://zenodo.org/api/records/4663679"
  }, 
  "created": "2021-04-06T06:52:39.815543+00:00", 
  "updated": "2021-04-06T12:27:19.876104+00:00", 
  "conceptrecid": "4663678", 
  "revision": 2, 
  "id": 4663679, 
  "metadata": {
    "access_right_category": "success", 
    "doi": "10.1016/j.addr.2021.03.018", 
    "description": "<p>Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conventional&nbsp;<em>in vitro</em>&nbsp;models include the lack of representation of the stromal population, the absence of a three-dimensional (3D) structure, and a poor representation of inter-tumor and intra-tumor heterogeneity. Herein, we review those cell culture strategies that aim to overcome these limitations, including cell co-cultures, advanced 3D cell cultures, patient-derived cells, bioprinting, and microfluidics systems. The&nbsp;<em>in vivo</em>&nbsp;evaluation of nanomedicines must consider critical parameters that include the enhanced permeability and retention effect, the host&#39;s immune status, and the site of tumor implantation. Here, we critically discuss the advantages and limitations of current&nbsp;<em>in vivo</em>&nbsp;models and report how the improved selection and application of breast cancer models can improve the clinical translation of nanomedicines.</p>", 
    "license": {
      "id": "CC-BY-4.0"
    }, 
    "title": "The Past, Present, and Future of Breast Cancer Models for Nanomedicine Development", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "4663678"
          }, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "4663679"
          }
        }
      ]
    }, 
    "grants": [
      {
        "code": "648831", 
        "links": {
          "self": "https://zenodo.org/api/grants/10.13039/501100000780::648831"
        }, 
        "title": "Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients", 
        "acronym": "MyNano", 
        "program": "H2020", 
        "funder": {
          "doi": "10.13039/501100000780", 
          "acronyms": [], 
          "name": "European Commission", 
          "links": {
            "self": "https://zenodo.org/api/funders/10.13039/501100000780"
          }
        }
      }
    ], 
    "keywords": [], 
    "publication_date": "2021-03-31", 
    "creators": [
      {
        "affiliation": "Centro de Investigaci\u00f3n Pr\u00edncipe Felipe, Polymer Therapeutics Lab, Av. Eduardo Primo Y\u00fafera 3, E-46012 Valencia, Spain", 
        "name": "Boix-Montesinos, Paz"
      }, 
      {
        "affiliation": "Centro de Investigaci\u00f3n Pr\u00edncipe Felipe, Polymer Therapeutics Laboratory and Targeted Therapies on Cancer and Inflammation Laboratory, Av. Eduardo Primo Y\u00fafera 3, E-46012 Valencia (Spain). Electronic address: psoriano@cipf.es.", 
        "name": "Soriano-Teruel, Paula M"
      }, 
      {
        "affiliation": "Centro de Investigaci\u00f3n Pr\u00edncipe Felipe, Polymer Therapeutics Lab, Av. Eduardo Primo Y\u00fafera 3, E-46012 Valencia, Spain", 
        "name": "Armi\u00f1\u00e1n, Ana"
      }, 
      {
        "affiliation": "Centro de Investigaci\u00f3n Pr\u00edncipe Felipe, Targeted Therapies on Cancer and Inflammation Laboratory, Av. Eduardo Primo Y\u00fafera 3, E-46012 Valencia (Spain). Electronic address: morzaez@cipf.es.", 
        "name": "Orz\u00e1ez, Mar"
      }, 
      {
        "affiliation": "Centro de Investigaci\u00f3n Pr\u00edncipe Felipe, Polymer Therapeutics Lab, Av. Eduardo Primo Y\u00fafera 3, E-46012 Valencia, Spain", 
        "name": "Vicent, Mar\u00eda J"
      }
    ], 
    "access_right": "open", 
    "resource_type": {
      "subtype": "article", 
      "type": "publication", 
      "title": "Journal article"
    }
  }
}
9
11
views
downloads
Views 9
Downloads 11
Data volume 25.9 MB
Unique views 9
Unique downloads 11

Share

Cite as